Menu
Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 7
Original Research
Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 19,423 | Dovepress* | 16,084+ | 3,759 | 19,843 | |
| PubMed Central* | 3,339 | 1,857 | 5,196 | ||
| Totals | 19,423 | 5,616 | 25,039 | ||
|
*Since 31 July 2012 +Since July 2016 |
|||||
View citations on PubMed Central and Google Scholar